Herpes virus infection of the peripheral nervous system

Handbook of Clinical Neurology

Volumn 115, Issue , 2013, Pages 543-558

  Steiner, Israel ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

Herpes simplex virus; Herpes viruses; Latent infection; Peripheral neuropathy; Varicella zoster virus

Indexed keywords

ARTICLE; HERPES SIMPLEX VIRUS; HERPES VIRUS; HERPES VIRUS INFECTION; HERPES VIRUSES; HUMAN; INFECTION; PATHOGENICITY; PERIPHERAL NEUROPATHY; VARICELLA ZOSTER VIRUS; VIROLOGY;

HERPES SIMPLEX VIRUS; HERPES VIRUSES; LATENT INFECTION; PERIPHERAL NEUROPATHY; VARICELLA-ZOSTER VIRUS;

HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 84881499569     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52902-2.00031-X     Document Type: Chapter

References (189)

1. Adour K.K., Ruboyianes J.M., Von Doersten P.G., et al. Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol 1996, 105:371-378.
2. Anders H.J., Goebel F.D. Cytomegalovirus polyradiculopathy in patients with AIDS. Clin Infect Dis 1998, 27:345-352.
3. Anderson J.P., Keal E.E. Cervical herpes zoster and diaphragmatic paralysis. Br J Dis Chest 1969, 63:222-226.
4. Appelbaum E., Kreps S.I., Sunshine A. Herpes zoster encephalitis. Am J Med 1962, 32:25-31.
5. Arbusow V., Derfuss T., Held K., et al. Latency of herpes simplex virus type-1 in human geniculate and vestibular ganglia is associated with infiltration of CD8+ T cells. J Med Virol 2010, 82:1917-1920.
6. Archambault P., Wise J.S., Rosen J., et al. Herpes zoster ophthalmoplegia: report of six cases. J Clin Neuroophthalmol 1998, 8:185-193.
7. Asbury A.K., Arnason B.G., Karp H.R., et al. Criteria for diagnosis of Guillain-Barre syndrome. Ann Neurol 1978, 3:565-566.
8. Asnis D.S., Micic L., Giaccio D. Ramsay Hunt syndrome presenting as a cranial polyneuropathy. Cutis 1996, 57:421-424.
9. Balfour H.H., Bean B., Laskin O.L., et al. Burroughs Wellcome Collaborative Study Group: acyclovir halts progression of herpes zoster in immunocompromised hosts. N Engl J Med 1983, 308:1448-1453.
10. Baron R., Binder A., Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010, 9:807-819.
11. Bean B., Braun C., Balfour H.H. Acyclovir therapy for acute herpes zoster. Lancet 1982, ii:118-121.
12. Behar R., Wiley C., McCutchan J.A. Cytomegalovirus polyradiculoneuropathy in acquired immune deficiency syndrome. Neurology 1987, 37:557-561.
13. Berger J.R., Houff S. Neurological complications of herpes simplex virus type 2 infection. Arch Neurol 2008, 65:596-600.
14. Bieger R.C., Van Scoy R.E., Smith T.F. Antibodies to varicella zoster in cerebrospinal fluid. Arch Neurol 1977, 34:489-491.
15. Birmanns B., Reibstein I., Steiner I. Characterization of an in vivo reactivation model of herpes simplex virus from mice trigeminal ganglia. J Gen Virol 1993, 74:2487-2491.
16. Black D., Stewart J., Melmed C. Sacral nerve dysfunction plus generalized polyneuropathy in herpes simplex genitalis. Ann Neurol 1983, 14:692.
17. Blumenthal D.T., Salzman K.L., Baringer J.R., et al. MRI abnormalities in chronic active varicella zoster infection. Neurology 2004, 63:1538-1539.
18. Bradley B.M., Bloom D.C., Cohrs R.J., et al. Herpes simplex virus-1 and varicella-zoster virus latency in human ganglia. J Neurovirol 2003, 9:194-204.
19. Brannagan T.H., Zhou Y. HIV-associated Guillain-Barré syndrome. J Neurol Sci 2003, 208:39-42.
20. Bullowa J.G.M., Wishik S.M. Complications of varicella. I. The occurrence among 2534 patients. Am J Dis Child 1935, 49:923-926.
21. Burgoon C., Burgoon J.S., Baldridge G.D. The natural history of herpes zoster. J Am Med Assoc 1957, 164:265-269.
22. Bustamante C.I., Wade J.C. Herpes simplex virus infection in the immunocompromised cancer patient. J Clin Oncol 1991, 9:1903-1915.
23. Buxbaum S., Geers M., Gross G., et al. Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed?. Med Microbiol Immunol (Berl) 2003, 192:177-181.
24. Caudie C., Quittard Pinon A., Taravel D., et al. Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients. J Neurol 2011, 258:1958-1964.
25. Cannon M.J., Schmid D.S., Hyde T.B. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010, 20:202-213.
26. Cesario T.C., Poland J.D., Wulff H., et al. Six years experience with herpes simplex virus in a children's home. Am J Epidemiol 1969, 90:416-422.
27. Chang T.W., Fiumara N.J., Weinstein L. Genital herpes: some clinical and laboratory observations. JAMA 1974, 229:544-545.
28. Clarke P., Beer T., Cohrs R., et al. Configuration of latent varicella-zoster virus DNA. J Virol 1995, 69:8151-8154.
29. Cohen B.A., McArthur J.C., Grohman S., et al. Neurologic prognosis of cytomegalovirus polyradiculopathy in AIDS. Neurology 1993, 43:493-499.
30. Cohen J.I., Brunell P.A., Straus S.E., et al. Recent advances in varicellazoster virus infection. Ann Intern Med 1999, 130:922-932.
31. Cohrs R.J., Randall J., Smith J., et al. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol 2000, 74:11464-11471.
32. Cohrs R.J., Gilden D.H., Kinchington P.R., et al. Varicella Zoster Virus gene 66 transcription and translation in latently infected human ganglia. J Virol 2003, 77:6660-6665.
33. Constantine V.S., Francis R.D., Montes L.F. Association of recurrent herpes simplex with neuralgia. J Am Med Assoc 1988, 205:181-183.
34. Corey L. Laboratory diagnosis of herpes simplex virus infections: principles guiding the development of rapid diagnostic tests. Diagn Microbiol Infect Dis 1986, 4:111S-119S.
35. Craig C., Nahmias A.J. Different patterns of neurologic involvement with herpes simplex virus type 1 & 2: isolation of herpes simplex virus type 2 from the buffy coat of two adults with meningitis. J Infect Dis 1973, 127:365-372.
36. Cresswell F., Eadie J., Longley N., et al. Severe Guillain-Barré syndrome following primary infection with varicella zoster virus in an adult. Int J Infect Dis 2010, 14:e161-e163.
37. Croen K.D., Ostrove J.M., Dragovic L., et al. Characterization of herpes simplex virus type 2 latency-associated transcription in human sacral ganglia and in cell culture. J Infect Dis 1991, 163:23-28.
38. Cumston C.G. The history of herpes from the earliest times to the nineteenth century. Ann Med Hist 1926, 8:284-291.
39. Dahl H., Marcoccia J., Linde A. Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patient. J Clin Microbiol 1997, 35:345-349.
40. Dayan A.D., Ogul E., Graveson G.S. Polyneuritis and herpes zoster. J Neurol Neurosurg Psychiatry 1972, 35:170-175.
41. Donahue J.G., Choo P.W., Manson J.E., et al. The incidence of herpes zoster. Arch Intern Med 1995, 155:1605-1609.
42. Douglas J.M., Critchlow C., Benedetti J., et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 1984, 310:1551-1556.
43. Dowling P.C., Cook S.D. Role of infection in Guillain-Barre syndrome: laboratory confirmation of herpesvirus in 41 cases. Ann Neurol 1981, 9:44-45.
44. Eberhardt O., Kuker W., Dichgans J., et al. HSV-2 sacral radiculitis (Elsberg syndrome). Neurology 2004, 63:758-759.
45. Eidelberg D., Sotrel A., Vogel H., et al. Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology 1986, 36:912-916.
46. Ellie E., Rozenberg F., Dousset V., et al. Herpes simplex virus type 2 ascending myeloradiculitis: MRI findings and rapid diagnosis by the polymerase chain method. J Neurol Neurosurg Psychiatry 1994, 57:869-870.
47. Enders G., Miller E. Epidemiology and herpes zoster in pregnancy and the newborn. Varicella Zoster Virus: Virology and Clinical Management 2000, 317-350. Cambridge University Press, Cambridge, UK. A. Arvin, A. Gershon (Eds.).
48. Fleming D.T., McQuillan G.M., Johnson R.E., et al. Herpes simplex virus type 2 in the United States, 1976-1994. N Engl J Med 1997, 337:1105-1111.
49. Froh K., Ahn K., Djaballah H., et al. A viral inhibitor of peptide transporters for antigen presentation. Nature 1995, 375:415-418.
50. Fuller G.N., Jacobs J.M., Guiloff R.J. Nature and incidence of peripheral nerve syndromes in HIV infections. J Neurol Neurosurg Psychiatry 1993, 56:372-381.
51. Gais S., Abrahamson R.H. Herpes zoster and its visceral manifestation. Am J Med Sci 1939, 197:817-825.
52. Gershon A., Steinberg S., Greenberg S., et al. Varicella-zoster-associated encephalitis: detection of specific antibody in cerebrospinal fluid. J Clin Microbiol 1980, 12:764-767.
53. Gilden D. Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia. J Intern Med 2011, 269:496-506.
54. Gilden D.H., Mahalingam R., Dueland A.N., et al. Herpes zoster: pathogenesis and latency. Progress in Medical Virology 1992, Vol. 39:19-75. S. Karger, Basel.
55. Gilden D., Cohrs R.J., Mahalingam R., et al. Neurological disease produced by varicella zoster virus reactivation without rash. Curr Top Microbiol Immunol 2010, 342:243-253.
56. Gnann J.W., Whitley R.J. Clinical practice: Herpes zoster. N Engl J Med 2002, 347:340-346.
57. Gnann J.W., Crumpacker C.S., Lalezari J.P., et al. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Antimicrob Agents Chemother 1998, 42:1139-1145.
58. Gold E. Serologic and virus-isolation studies of patients with varicella or herpes zoster infections. N Engl J Med 1966, 274:181-185.
59. Goldenberg D., Mador N., Ball M.J., et al. The abundant latency-associated transcripts of herpes simplex virus type 1 are bound to polyribosomes in cultured neuronal cells and during latent infection in mouse trigeminal ganglia. J Virol 1997, 71:2897-2904.
60. Goldstein L.C., Corey L., McDougall J.K., et al. Monoclonal antibodies to herpes simplex viruses: use in antigenetic typing and rapid diagnosis. J Infect Dis 1983, 147:829-837.
61. Gominak S., Cros D., Paydarfar D. Herpes simplex labialis and trigeminal neuropathy. Neurology 1990, 40:151-152.
62. Goodpasture E.W. Herpetic infections with special reference to involvement of the nervous system. Medicine 1929, 8:223-243.
63. Greenberg J. Herpes zoster with motor involvement. J Am Med Assoc 1970, 212:322.
64. Grose C. Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics 1981, 68:735-737.
65. Gupta S.K., Helal B.H., Kiely P. The prognosis in zoster paralysis. J Bone Joint Surg 1969, 51B:593-603.
66. Handler C.E., Perkin G.D. Radiculomyelopathy due to genital herpes. Lancet 1982, ii:987-988.
67. Harnisch J.P. Zoster in the elderly: Clinical, immunologic and therapeutic considerations. J Am Geriatr Soc 1984, 32:789-793.
68. Harpaz R., Ortega-Sanchez I.R., Seward J.F., et al. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008, 57:1-30.
69. Haymaker W., Kernohan J.W. The Landry-Guillain-Barre syndrome. Medicine 1949, 28:59-141.
70. Heininger U., Seward J.F. Varicella. Lancet 2006, 368:1365-1376.
71. Hill A., Jugovic P., York I., et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995, 375:411-415.
72. Hope-Simpson R.E. The nature of herpes zoster: a long term study and a new hypothesis. Proc R Soc Med 1965, 58:9-20.
73. Jacobs B.C., Rothbarth P.H., van der Meché F.G., et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 1998, 51:1110-1115.
74. Jellinek E.H., Tulloch W.S. Herpes zoster with dysfunction of bladder and anus. Lancet 1976, ii:1219-1222.
75. Juel-Jensen E. The natural history of Shingles. Events associated with reactivation of varicella-zoster virus. J R Coll Gen Pract 1970, 20:323-327.
76. Kennedy P.G.E. Neurological complications of varicella-zoster virus. Infections of the Nervous System 1987, 177-208. Butterworth, London. P.G.E. Kennedy, R.T. Johnson (Eds.).
77. Kennedy P.G., Steiner I. A molecular and cellular model to explain the differences in reactivation from latency by herpes simplex and varicella-zoster viruses. Neuropathol Appl Neurobiol 1994, 20:368-374.
78. Kennedy P.G.E., Grinfeld E., Gow J.W. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci U S A 1998, 95:4658-4662.
79. Kennedy P.G.E., Grinfeld, Bell J.E. Varicella-Zoster virus gene expression in latently infected and explanted human ganglia. J Virol 2000, 74:11893-11898.
80. Kim Y.S., Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 1993, 17:32-37.
81. Kimberlin D.W. Herpes simplex virus infections in neonates and early childhood. Semin Pediatr Infect Dis 2005, 16:271-281.
82. Knaup B., Schunemann S., Wolff M.H. Subclinical reactivation of herpes simplex virus type 1 in the oral cavity. Oral Microbiol Immunol 2000, 15:281-283.
83. Knox J.D.E., Levy R., Simpson J.A. Herpes zoster and the Landry-Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1961, 24:167-172.
84. Krause P.R., Stanberry L.R., Bourne N., et al. Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs. J Exp Med 1995, 181:297-306.
85. Kukimoto N., Ikeda M., Yamada K., et al. Viral infection in acute peripheral facial paralysis: nationwide analysis centering on CF. Acta Otolaryngol 1988, 446:17-22.
86. LaGuardia J.J., Cohrs R.J., Gilden D.H. Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells. J Virol 1999, 73:8571-8577.
87. Lakeman F.D., Whitley R.J. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1995, 171:857-863.
88. Lampert P., Garrett R., Powell H. Demyelination in experimental and Marek's disease virus-induced neuritis: comparative electron microscopy studies. Acta Neuropathol (Berl) 1977, 40:103-110.
89. Leung T.F., Li C.K., Hung E.C., et al. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers. Eur J Haematol 2004, 72:353-357.
90. Littler E., Stuart A.D., Chee M.S. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleotide analogue ganciclovir. Nature 1992, 358:160-162.
91. Lockhart P., Daly F., Pitkethly M., et al. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2009, 4. CD001869.
92. Looker K.J., Garnett G.P., Schmid G.P. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ 2008, 86:805-812. A.
93. Mastroianni C.M., Sebastiani G., Folgori F., et al. Detection of cytomegalovirus-matrix protein (pp65) in leukocytes of HIV-infected patients with painful peripheral neuropathy. J Med Virol 1994, 44:172-175.
94. Max M.B. Treatment of post herpetic Neuralgia: antidepressants. Ann Neurol 1994, 35:S50-S53.
95. Mazur M.H., Dolin R. Herpes zoster at the NIH: A 20 year experience. Am J Med 1978, 65:738-743.
96. McCormick D.P. Herpes simplex virus as a cause of Bell's palsy. Lancet 1972, 1:937.
97. McCutchan A. Cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis 1995, 20:747-754.
98. McKendell R.R., Klawans H.L. Nervous system complications of varicella zoster virus. Handbook of Clinical Neurology 1978, Vol. 34:161-183. Elesvier, Amsterdam, North-Holland. P.J. Vinken, G.W. Bruyn (Eds.).
99. Meier J.L., Straus S.E. Comparative biology of latent varicella-zoster virus and herpes simplex virus infections. J Infect Dis 1992, 166:S13-S23.
100. Melbye M., Grossman R.J., Goedert J.J., et al. Risk of AIDS after herpes zoster. Lancet 1987, i:728-731.
101. Mellerick D.M., Fraser N.W. Physical state of the latent herpes simplex virus genome in mouse model system: evidence suggesting an episomal state. Virology 1987, 158:265-275.
102. Merchut M.P., Gruener G. Segmental zoster paresis of limbs. Electromyogr Clin Neurophysiol 1996, 36:369-375.
103. Meyer P.A., Seward J.F., Jumaan A.O., et al. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 2000, 182:383-390.
104. Miller H.G., Stanton J.B., Gibbons J.L. Para-infectious encephalomyelitis and related syndromes. Q J Med 1956, 25:427-505.
105. Miller R.G., Storey J.R., Greco M. Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 1990, 40:569-574.
106. Momin F., Chandrasekar P.H. Animicrobial prophylaxis in bone marrow transplantation. Ann Intern Med 1995, 123:205-215.
107. Morens D.M., Bregman D.J., West M., et al. An outbreak of varicella-zoster virus infection among cancer patients. Ann Intern Med 1980, 93:414-419.
108. Morgello S., Simpson D.M. Multifocal cytomegalovirus demyelinative polyneuropathy associated with AIDS. Muscle Nerve 1994, 17:176-182.
109. Moriyama K., Mohri S., Watanabe T., et al. Latent infection of SCID mice with herpes simplex virus 1 and lethal cutaneous lesions in pregnancy. Microbiol Immunol 1992, 36:841-853.
110. Muñoz-Sellart M., García-Vidal C., Martínez-Yelamos S., et al. Peripheral facial palsy after varicella: report of two cases and review of the literature. Enferm Infecc Microbiol Clin 2010, 28:504-508.
111. Murakami S., Mizobuchi M., Nakashiro Y., et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneural fluid and muscle. Ann Intern Med 1996, 127:27-30.
112. Nahass G.T., Mandel M.J., Cook S., et al. Detection of herpes simplex and varicella-zoster infection from cutaneous lesions in different clinical stages with the polymerase chain reaction. J Am Acad Dermatol 1995, 32:730-733.
113. Nahmias A.J., Dowdle W.R., Naib Z.M., et al. Genital infection with type 2 herpes virus huminis. A commonly occurring venereal disease. Br J Vener Dis 1969, 45:294-298.
114. Nahmias A.J., Lee F.K., Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990, 69:19-36.
115. Neville B.G.R., Sladen G.E. Acute autonomic neuropathy following primary herpes simplex infection. J Neurol Neurosurg Psychiatry 1984, 47:648-650.
116. Nilsen A., Myremel H. Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet Gynecol Scand 2000, 79:693-696.
117. Oaks J.E., Lausch R.N. Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia. J Virol 1984, 51:656-661.
118. Oldstone M.B. Molecular anatomy of viral persistence. J Virol 1991, 65:6381-6386.
119. Olivarius B.F., Buhl M. Herpes simplex virus and Guillain-Barre polyradiculitis. Br Med J 1975, i:192-193.
120. Osterrieder N., Kamil J.P., Schumacher D., et al. Marek's disease virus: from miasma to model. Nat Rev Microbiol 2006, 4:283-294.
121. Oxman M.N., Levin M.J., Johnson G.R., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352:2271-2284.
122. Pepose J.S., Stevens J.G., Cook M., et al. Marek's disease as an animal model for the Landry-Guillain-Barre syndrome. Latent infection restricted to neuronal supporting cells and accompanied by specific immune response to peripheral nerve myelin. Am J Pathol 1981, 103:309-320.
123. Perng G.C., Jones C., Ciacci-Zanella J., et al. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 2000, 287:1500-1503.
124. Peters A.C.B., Versteeg J., Bots G.T.A.M., et al. Nervous system complications of herpes zoster: immunofluorescent demonstration of varicella zoster antigen in CSF cells. J Neurol Neurosurg Psychiatry 1979, 42:452-457.
125. Peterslund N.A., Setyer-Hansen K., Ipsen J., et al. Acyclovir in herpes zoster. Lancet 1981, ii:827-830.
126. Pinot de Moira A., Nardone A. Varicella zoster virus vaccination policies and surveillance strategies in Europe. Euro Surveill 2005, 10:43-45. ESEN2 group.
127. Preblud S.R. Varicella: complications and costs. Pediatrics 1986, 78:728-735.
128. Quan D., Hammack B.N., Kittelson J., et al. Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir. Arch Neurol 2006, 63:940-942.
129. Rab S.M., Choudhury G.M. Landry-Guillain-Barre syndrome after chickenpox. N Engl J Med 1963, 268:200-201.
130. Raggozino M.W., Melton L.J., Kurland L.T. Risk of cancer after herpes zoster: a population-based study. N Engl J Med 1982, 307:393-397.
131. Reeves W.C., Corey L., Adams H.G., et al. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med 1981, 305:315-319.
132. Revello M.G., Percivalle E., Sarasini A., et al. Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. J Infect Dis 1994, 170:1275-1279.
133. Roberts C.M., Pfister J.R., Spear S.J. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003, 30:797-800.
134. Rock D.L., Fraser N.W. Detection of HSV-1 genome in the central nervous system of latently infected mice. Nature 1983, 302:523-525.
135. Rogers R.S., Tindall J.P. Herpes zoster in the elderly. Postgrad Med 1971, 50:153-157.
136. Roizman B., Whitley R.J. The nine ages of herpes simplex virus. Herpes 2001, 8:23-27.
137. Roullet E., Assuerrus V., Gozlan J., et al. Cytomegalovirus multifocal neuropathy in AIDS. Analysis of 15 consecutive cases. Neurology 1994, 44:2174-2182.
138. Rowbotham M.C., Davies P.S., Foelds H.L. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 1995, 37:246-253.
139. Said G., Lacroix C., Chemouilli P., et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 1991, 29:139-146.
140. Schimpff J., Serpick A., Stoler B., et al. Varicella-zoster infection in patients with cancer. Ann Intern Med 1972, 765:241-254.
141. Schulz P., Arbusow V., Strupp M., et al. Highly variable distribution of HSV-1 specific DNA in human geniculate, vestibular and spiral ganglia. Neurosci Lett 1988, 252:139-142.
142. Sengupta N., Booy R., Schmitt H.J., et al. Varicella vaccination in Europe: are we ready for a universal childhood programme?. Eur J Pediatr 2008, 167:47-55.
143. Seward J., Galil K., Wharton M. Epidemiology of varicella. Varicella-Zoster Virus 2000, 187-205. Cambridge University Press, Cambridge. A. Arvin, A. Gershon (Eds.).
144. Shen W., Sa e Silva M., Jaber T., et al. Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis. J Virol 2009, 83:9131-9139.
145. Simmons A., Tscharke D.C. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implication for the fate of the virally infected neurons. J Exp Med 1992, 175:1337-1344.
146. Simpson D.M., Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994, 121:769-785.
147. Sinclair J., Sissons P. Latency and reactivation of human cytomegalovirus. J Gen Virol 2006, 87:1763-1779.
148. Smith J.S., Robinson N.J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002, 186:S3-S28.
149. So Y.T., Olney R.K. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann Neurol 1994, 35:53-58.
150. Spivack J.G., Fraser N.W. Detection of herpes simplex type 1 transcripts during latent infection in mice. J Virol 1987, 61:3841-3847.
151. Steele R.W., Keeney R.E., Bradsher R.W., et al. Treatment of varicella-zoster meningoencephalitis with acyclovir: demonstration of virus in cerebrospinal fluid by electron microscopy. Am J Clin Pathol 1983, 80:57-60.
152. Steiner I. Can vaccinating older adults against varicella zoster virus prevent herpes zoster and postherpetic neuralgia?. Nat Clin Pract Neurol 2005, 1:18-19.
153. Steiner I., Abramsky O. Immunology of Guillain-Barre syndrome. Springer Semin Immunopathol 1985, 8:165-176.
154. Steiner I., Kennedy P.G. Herpes simplex virus latency in the nervous system: a new model. Neuropathol Appl Neurobiol 1991, 17:433-440.
155. Steiner I., Kennedy P.G.E. The molecular biology of herpes simplex virus type 1 latency in the nervous system. Mol Neurobiol 1993, 7:137-159.
156. Steiner I., Kennedy P.G.E. Herpes simplex virus type 1 latent infection in the nervous system. J Neurovirol 1995, 1:19-29.
157. Steiner I., Mattan Y. Bell's palsy and herpes viruses: To (acyclo)vir or not to (acyclo)vir?. J Neurol Sci 1999, 170:19-23.
158. Steiner I., Spivack J.G., O'Boyle D.R., et al. Latent herpes virus type 1 transcription in human trigeminal ganglia. J Virol 1988, 62:3493-3496.
159. Steiner I., Spivack J.G., Lirette R.P., et al. Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J 1989, 8:505-511.
160. Steiner I., Spivack J.G., Deshmane S.L., et al. A herpes simplex virus type 1 mutant containing a non-transinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. J Virol 1990, 64:1630-1638.
161. Steiner I., Steiner-Birmanns B., Levin N., et al. Spinal cord involvement in uncomplicated herpes zoster. Clin Diagn Lab Immunol 2001, 8:850-851.
162. Steiner I., Kennedy P.G.E., Pachner A. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol 2007, 6:1015-1028.
163. Steiner I., Rosenberg G., Wirguin I. Transient immunosuppression: a bridge between infection and the atypical autoimmunity of Guillain-Barre syndrome?. Clin Exp Immunol 2010, 162:32-40.
164. Steininger C., Popow-Kraupp T., Seiser A., et al. Presence of cytomegalovirus in cerebrospinal fluid of patients with Guillain-Barre syndrome. J Infect Dis 2004, 189:984-989.
165. Stevens J.G., Wagner E.K., Devi-Rao G.B., et al. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 1987, 235:1056-1059.
166. Straus S.E., Rakiff H.E., Seidlin M., et al. Suppression of frequently recurring genital herpes: a placebo-controlled double blind trial of oral acyclovir. N Engl J Med 1984, 310:1545-1550.
167. Straus S.E., Seidlin M., Rakiff H., et al. Oral acyclovir to suppress recurring herpes simplex virus infections in immuno-deficient patients. Ann Intern Med 1984, 100:522-524.
168. Sullivan V., Talarico C.L., Stanat S.C., et al. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus infected cells. Nature 1992, 358:162-164.
169. Sullivan F.M., Swan I.R., Donnan P.T., et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 2007, 357:1598-1607.
170. Sweeney C.J., Gilden D.H. Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry 2001, 71:149-154.
171. Tang S., Bertke A.S., Patel A., et al. Herpes simplex virus-2 miR-H6 is a novel LAT-associated microRNA, but reduction of its expression does not influence viral latency establishment or recurrence phenotype. J Virol 2011, 85:4501-4509.
172. Theil D., Derfuss T., Paripovic I., et al. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 2003, 163:2179-2184.
173. Thomas E.J., Howard F.M. Segmental zoster paresis. A disease profile. Neurology 1972, 22:459-466.
174. Thomas M., Robertson W.J. Dermal transmission of virus as a cause of shingles. Lancet 1971, ii:1349-1350.
175. Vafai A., Wellish M., Gilden D.H. Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc Natl Acad Sci U S A 1988, 85:2767-2770.
176. Valyi-Nagy T., Deshmane S.L., Raengsakulrach B., et al. Herpes simplex virus type 1 mutant strain in 1814 establishes a unique, slowly progressing infection in SCID mice. J Virol 1992, 66:7336-7345.
177. van de Perre P., Bakkeres E., Battungwany J., et al. Herpes zoster in African patients: an early manifestation of HIV infection. Scand J Infect Dis 1988, 20:277-282.
178. Verma A. Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst 2001, 6:8-13.
179. Visser L.H., Van Der Méche F.G., Meulstee J., et al. Cytomegalovirus infection and Guillain-Barre syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barre Study Group. Neurology 1996, 47:668-673.
180. Wald A., Zeh J., Selke S., et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000, 342:844-850.
181. Wassilew S.W., Wutzler P. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study. Antiviral Res 2003, 59:49-56.
182. Watson C.P.N., Morshead C., Van der Kooy D., et al. Postherpetic neuralgia: post-mortem analysis of a case. Pain 1988, 34:129-138.
183. Watson C.P., Tyler K.L., Bickers D.R., et al. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993, 15:510-526.
184. Whitcher J.P., Srinivasan M., Upadhyay M.P. Corneal blindness: a global perspective. Bull World Health Organ 2001, 79:214-221.
185. Whitley R.J. Herpes simplex viruses. Virology 1990, 1843-1886. Raven Press, New York. 2nd edn. B.N. Fields, D.M. Knipe (Eds.).
186. Wolf D.G., Spector S.A. Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid. J Infect Dis 1992, 166:1412-1415.
187. Wolf D.G., Lee D.J., Spector S.A. Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease. Antimicrob Agents Chemother 1995, 39:2552-2554.
188. Wulff E.A., Wang A.K., Simpson D.M. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs 2000, 59:1251-1260.
189. Xu F., Sternberg M.R., Kottiri B.J., et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006, 296:964-973.